As of May 22
| +0.46 / +3.19%|
The 1 analysts offering 12-month price forecasts for Assembly Biosciences Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a -56.29% decrease from the last price of 14.87.
The current consensus among 1 polled investment analysts is to Hold stock in Assembly Biosciences Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.